S&P 500

5.647,75

0,29%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

HSP

Hospira (HSP)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:HSP

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
28/07/2014	13:25	Dow Jones News	EUROPE MARKETS: Ryanair Shines In Downbeat European Market	NYSE:HSP
28/07/2014	12:30	Dow Jones News	Correction to U.S. Hot Stocks: Hot Stocks to Watch	NYSE:HSP
28/07/2014	10:39	Dow Jones News	U.S. Hot Stocks: Hot Stocks to Watch	NYSE:HSP
28/07/2014	06:32	Dow Jones News	EUROPE MARKETS: Ryanair Tops Stoxx 600 After Profit Soars 152%	NYSE:HSP
27/07/2014	18:17	Dow Jones News	Danone May Sell Medical Nutrition Unit to Hospira -- FT	NYSE:HSP
24/07/2014	05:26	PR Newswire (US)	Biosimilar Retacrit™ Effective in Chemotherapy-Induced Anemia - New Publication in BMC Cancer of ORHEO Study Results	NYSE:HSP
16/07/2014	17:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:HSP
04/07/2014	15:09	PR Newswire (US)	Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D Facility	NYSE:HSP
01/07/2014	11:48	PR Newswire (US)	Hospira to Host Conference Call for Second-Quarter 2014 Results	NYSE:HSP
20/06/2014	02:30	Dow Jones News	TPG, Carlyle Gauge Interest in Possible Healthscope IPO	NYSE:HSP
13/06/2014	07:21	PR Newswire (US)	Hospira Shares Results From Randomised Trials Showing Biosimilar Monoclonal Antibody, Inflectra™, Demonstrates Comparable R...	NYSE:HSP
06/06/2014	15:30	PR Newswire (Canada)	Hospira Statement Regarding Paclitaxel Supply and Pricing	NYSE:HSP
06/06/2014	15:30	PR Newswire (Canada)	Énoncé de Hospira concernant la fourniture et le prix du paclitaxel	NYSE:HSP
02/06/2014	14:10	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	NYSE:HSP
12/05/2014	13:35	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:HSP
07/05/2014	13:45	PR Newswire (US)	Hospira Convenes Its 2014 Annual Meeting of Shareholders	NYSE:HSP
30/04/2014	08:42	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:HSP
30/04/2014	08:30	PR Newswire (US)	Hospira Reports First-Quarter 2014 Results	NYSE:HSP
28/04/2014	06:03	PR Newswire (US)	Hospira Presents Results From PASCO I (Post-Authorization Safety Cohort Observational Study) for Biosimilar Retacrit™/Silap...	NYSE:HSP
22/04/2014	17:49	PR Newswire (US)	Hospira to Present at Upcoming Investor Conferences	NYSE:HSP
11/04/2014	09:00	PR Newswire (US)	Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Acta...	NYSE:HSP
10/04/2014	13:30	PR Newswire (US)	Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines	NYSE:HSP
31/03/2014	15:36	PR Newswire (US)	Hospira to Host Conference Call for First-Quarter 2014 Results	NYSE:HSP
27/03/2014	11:30	PR Newswire (US)	Hospira's TheraDoc™ Infection Control Assistant™ Ranked #1 in Its Category by KLAS for Second Consecutive Year	NYSE:HSP
21/03/2014	17:56	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NYSE:HSP
21/03/2014	17:39	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NYSE:HSP
12/03/2014	16:54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:HSP
11/03/2014	10:19	PR Newswire (US)	Appointments, Financial Reports, and FDA Approvals - Analyst Notes on Hospira, Karyopharm, Revance, Pluristem, and Sunesis	NYSE:HSP
04/03/2014	11:34	PR Newswire (US)	Hospira Names David J. Endicott President of Medical Devices	NYSE:HSP
12/02/2014	12:21	Dow Jones News	US Hot Stocks: Hot Stocks to Watch	NYSE:HSP